News from pliant therapeutics, inc. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Nov 19, 2020, 08:00 ET Pliant Therapeutics To Participate In The Piper Sandler 32nd Annual Virtual Healthcare Conference

Pliant Therapeutics, Inc. (Nasdaq: PLRX), a clinical stage biopharmaceutical company focused on discovering and developing novel therapies for the...

Nov 10, 2020, 16:05 ET Pliant Therapeutics Provides Corporate Update and Reports Third Quarter 2020 Financial Results

Pliant Therapeutics, Inc. (Nasdaq: PLRX) (the Company), a clinical stage biotechnology company focused on discovering and developing novel...

Nov 09, 2020, 08:00 ET Pliant Therapeutics to Present Data at The Liver Meeting® 2020

Pliant Therapeutics, Inc. (Nasdaq: PLRX), a clinical stage biopharmaceutical company focused on discovering and developing novel therapies for the...

Oct 05, 2020, 08:00 ET Pliant Therapeutics Appoints Mike Ouimette as General Counsel

Pliant Therapeutics, Inc. (Nasdaq: PLRX), a clinical stage biotechnology company focused on discovering and developing novel therapeutics for the...

Sep 24, 2020, 08:00 ET Pliant Therapeutics Presents Data at American Thoracic Society 2020 Virtual Sessions

Pliant Therapeutics, Inc. (Nasdaq: PLRX), a clinical stage biotechnology company focused on discovering and developing novel therapeutics for the...

Sep 04, 2020, 08:00 ET Pliant Therapeutics To Participate In Upcoming Virtual Investor Conferences

Pliant Therapeutics, Inc. (Nasdaq: PLRX), a clinical stage biotechnology company focused on discovering and developing novel therapeutics for the...

Aug 27, 2020, 06:00 ET Pliant Therapeutics Presents Data at The Digital International Liver Congress™ 2020

Pliant Therapeutics, Inc. (Nasdaq: PLRX), a clinical stage biotechnology company focused on discovering and developing novel therapeutics for the...

Aug 11, 2020, 16:05 ET Pliant Therapeutics Provides Corporate Update and Announces Second-Quarter 2020 Financial Results

Pliant Therapeutics, Inc. (Nasdaq: PLRX), a clinical stage biotechnology company focused on discovering and developing novel therapeutics for the...

Jun 05, 2020, 16:05 ET Pliant Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Option to Purchase Additional Shares

Pliant Therapeutics, Inc. (Nasdaq: PLRX), a clinical stage biopharmaceutical company focused on discovering and developing novel therapies for the...

Jun 02, 2020, 21:56 ET Pliant Therapeutics Announces Pricing of Initial Public Offering

Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of...

Mar 23, 2020, 08:00 ET Pliant Therapeutics Initiates First-in-Human Clinical Trial of PLN-1474 for the Potential Treatment of Liver Fibrosis

Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of...

Mar 03, 2020, 08:00 ET Pliant Therapeutics Raises $100 Million in Series C Financing to Advance Therapies for Fibrotic Diseases

Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of...

Jan 08, 2020, 08:00 ET Pliant Therapeutics Appoints Gayle Crowell to its Board of Directors

Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of...

Oct 31, 2019, 08:00 ET Pliant Therapeutics to Present Preclinical Data in Primary Sclerosing Cholangitis at The Liver Meeting 2019

Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of...

Oct 23, 2019, 08:00 ET Pliant Therapeutics Announces Strategic Collaboration to Develop Novel Therapies for NASH and Fibrotic Diseases

Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of...

Oct 15, 2019, 08:00 ET Pliant Therapeutics Announces Publication Demonstrating Feasibility of Positron Emission Tomography (PET) Tracers for Imaging Fibrosis in Patients with Idiopathic Pulmonary Fibrosis

Pliant Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on the discovery and development of novel therapies for the treatment...

Jun 27, 2019, 08:00 ET Pliant Therapeutics Reports Positive Results of Phase 1b Clinical Study Supporting Advancement of PLN-74809 for Treatment of Idiopathic Pulmonary Fibrosis

Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of...

Apr 09, 2019, 08:02 ET Pliant Therapeutics Reports Positive Results of Phase 1 Clinical Study Support Advancement of PLN-74809 for Idiopathic Pulmonary Fibrosis

Pliant Therapeutics, Inc., a biotechnology company focused on discovering, developing and commercializing treatments for fibrotic diseases, today...

Mar 28, 2019, 08:00 ET Pliant Therapeutics Presents Data in Human NASH Liver Tissue at The International Liver Congress 2019 Hosted by the European Association for the Study of the Liver (EASL)

Pliant Therapeutics, Inc., a biotechnology company focused on discovering, developing and commercializing treatments for fibrotic diseases, today...

Mar 14, 2019, 08:00 ET Pliant Therapeutics Appoints Smital Shah to its Board of Directors

Pliant Therapeutics, Inc., a biotechnology company focused on discovering, developing and commercializing treatments for fibrotic diseases, today...

Feb 13, 2019, 08:00 ET Pliant Therapeutics to Present at Upcoming Investor Conferences

Pliant Therapeutics, Inc., a biotechnology company focused on discovering, developing and commercializing treatments for fibrotic diseases, today...

Jan 03, 2019, 08:00 ET Pliant Therapeutics Appoints Keith Cummings as Chief Financial Officer and Eduard Gorina as Vice President, Clinical Development

Pliant Therapeutics, Inc., a biotechnology company unraveling and targeting the key biological pathways driving fibrosis, today announced that Keith...

Jan 03, 2019, 08:00 ET Pliant Therapeutics Initiates Phase 1 Clinical Study of PLN-74809

Pliant Therapeutics, Inc., a biotechnology company focused on discovering, developing and commercializing treatments for fibrotic diseases, today...

Dec 27, 2018, 08:03 ET Pliant Therapeutics to Present at 37th Annual J.P. Morgan Healthcare Conference

Pliant Therapeutics, Inc., a biotechnology company focused on discovering, developing and commercializing treatments for fibrotic diseases, today...

Nov 20, 2018, 08:00 ET Pliant Therapeutics Receives FDA Orphan Drug Designation for Lead Program PLN-74809 in Primary Sclerosing Cholangitis

Pliant Therapeutics, Inc., a biotechnology company focused on discovering, developing and commercializing treatments for fibrotic diseases, today...